Author = Hamid Reza Rasekh
Number of Articles: 14
1. Supply Chain Challenges in Pharmaceutical Manufacturing Companies: Using Qualitative System Dynamics Methodology

Volume 18, Issue 2, Spring 2019, Pages 1103-1116

Asiye Moosivand; Ali Rajabzadeh Ghatari; Hamid Reza Rasekh


2. The Availability and Affordability of Cardiovascular Medicines for secondary prevention in Tehran Province

Volume 17, Special Issue 1, Winter 2018, Pages 64-72

Ali Vasheghani Farahani; Jamshid Salamzadeh; Hamid Reza Rasekh; Sheyda Najafi; Vahideh Mosadegh


3. Monetary value of quality-adjusted life years (QALY) among patients with cardiovascular disease: a willingness to pay study

Volume 16, Issue 2, Spring 2017, Pages 820-830

najmeh moradi; Arash Rashidian; Hamid Rasekh; teymoor mohammadi; Mahnoosh Foroughi; Alireza Olyaeemanesh


4. New Product Development in the Pharmaceutical Industry: Evidence from Iran

Volume 16, Issue 2, Spring 2017, Pages 831-843

Nazila Yousefi; Gholamhossein Mehralian; HamidReza Rasekh; Mina Yousefi


5. Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven™) and Activated Prothrombin Complex Concentrates (FEIBA™) to Treat Hemophilia A Patients with Inhibitors in Iran

Volume 15, Issue 2, Spring 2016, Pages 669-677

Mina Golestani; peyman eshghi; Hamid Reza Rasekh; Abdoll Majid Cheraghali; Jamshid Salamzadeh; Majid Naderi; Mohammad Reza Managhchi; Hamid Hoorfar; Gholam Reza Toogeh; Ali Imani; Mohammad Taghi Khodayari; Behnaz Habibpanah; Razieh Hantooshzadeh


6. Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model

Volume 15, Issue 1, Winter 2016, Pages 369-381

amir viyanchi; Ali Rajabzadeh Ghatari; Hamid Reza Rasekh; Hamid Reza Safi-khani


7. Selecting the acceptance criteria of medicines in the reimbursement list of public health insurance of Iran, using the “Borda”method: a pilot study

Volume 14, Issue 4, Autumn 2015, Pages 1305-1316

amir viyanchi; Hamid Reza Rasekh; Ali Rajabzadeh Ghatari; Hamid Reza SafiKhani


8. Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran

Volume 14, Issue 2, Spring 2015, Pages 635-649

Mohsen Khatibi; Hamid Reaz Rasekh


9. An Analysis of Job Satisfaction among Iranian Pharmacists through various Job Characteristics

Volume 13, Issue 3, Summer 2014, Pages 1087-1096

Mohamad Javad Foroughi Moghadam; Farzad Peiravian; Azadeh Naderi; Ali Rajabzadeh; Hamid Reza Rasekh


10. Drug Literacy in Iran: the Experience of Using “The Single Item Health Literacy Screening (SILS) Tool”

Volume 13, Supplement, Winter 2014, Pages 217-224

Farzad Peiravian; Hamid Reza Rasekh; Hasan Jahani Hashemi; Navid Mohammadi; Nahid Jafari; Kianoosh Fardi


11. Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

Volume 13, Supplement, Winter 2014, Pages 225-234

Mohsen Khatibi; Hamid Reza Rasekh; Zohreh Shahverdi; Hamid Reza Jamshidi


12. Costs of treatment after renal transplantation: is it worth to pay more?

Volume 13, Issue 1, Winter 2014, Pages 271-278

Jamshid Salamzadeh; Naghmeh Foroutan; Hamid Reza Jamshidi; Hamid Reza Rasekh; Ali Rajabzadeh; Arash Foroutan; Mohsen Nafar


13. Developing a Model for Agile Supply: an Empirical Study from Iranian Pharmaceutical Supply Chain

Volume 12, Supplement, Winter 2013, Pages 193-205

Ali Rajabzadeh; Gholamhossein Mehralian; Forouzandeh Zarenezhadb; Hamid Reza Rasekh


14. Situation Analysis of R & D Activities: An Empirical Study in Iranian Pharmaceutical Companies

Volume 11, Issue 4, Autumn 2012, Pages 1013-1025

Hamid Reza Rasekh; Gholamhossein Mehralian; Abbas Ali Vatankhah-Mohammadabadi